Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino

Sarah E LeBoeuf1, Warren L Wu1, Triantafyllia R Karakousi1

  • 1Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.

Cell Metabolism
|December 10, 2019
PubMed

Insights

Lung adenocarcinoma with KEAP1/NRF2 mutations depends on non-essential amino acids (NEAAs) due to Nrf2-driven glutamate secretion. Restricting NEAAs or glutamate offers a targeted therapy approach.

Area of Science:

  • Oncology
  • Metabolic pathways
  • Cancer metabolism

Background:

  • Tumorigenesis involves metabolic pathway rewiring, leading to nutrient dependencies.
  • KEAP1/NRF2-mutated lung adenocarcinoma activates oxidative stress response, requiring metabolic adaptations for antioxidant production.

Purpose of the Study:

  • To investigate the metabolic dependencies of cancers with high antioxidant capacity.
  • To identify therapeutic strategies targeting NRF2-activated lung adenocarcinoma.

Main Methods:

  • Analysis of metabolic rewiring in KEAP1/NRF2-mutated lung adenocarcinoma.
  • Investigating the role of Nrf2-dependent glutamate secretion via system xc- (XCT).
  • Evaluating therapeutic targeting through dietary restriction or enzymatic depletion of NEAAs and glutaminase inhibition.

Main Results:

  • Cancers with high antioxidant capacity exhibit dependency on exogenous non-essential amino acids (NEAAs).
  • Nrf2-driven glutamate secretion via XCT limits intracellular glutamate for NEAA synthesis.
  • Dietary restriction or enzymatic depletion of NEAAs, and glutaminase inhibition, show therapeutic potential.

Conclusions:

  • Nrf2-activated cancers have a specific dependency on exogenous NEAAs.
  • Targeting NEAA metabolism or glutamate synthesis presents a viable therapeutic strategy for NRF2-driven cancers.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K